134 related articles for article (PubMed ID: 10659403)
1. Palonosetron. RS 25259, RS 25259 197.
Drugs R D; 1999 Oct; 2(4):251-2. PubMed ID: 10659403
[No Abstract] [Full Text] [Related]
2. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
Jin Y; Sun W; Gu D; Yang J; Xu Z; Chen J
Eur J Cancer Care (Engl); 2013 Jan; 22(1):41-50. PubMed ID: 22519361
[TBL] [Abstract][Full Text] [Related]
3. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
Rubenstein EB
Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
[TBL] [Abstract][Full Text] [Related]
4. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
5. Palonosetron: a second-generation 5-hydroxytryptamine receptor antagonist.
Navari RM
Future Oncol; 2006 Oct; 2(5):591-602. PubMed ID: 17026451
[TBL] [Abstract][Full Text] [Related]
6. Palonosetron-induced migraine-type headache.
Jain A
Can J Anaesth; 2011 Feb; 58(2):230-1. PubMed ID: 21132477
[No Abstract] [Full Text] [Related]
7. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
[TBL] [Abstract][Full Text] [Related]
8. [Meta-analysis of phase III studies with palonosetron in the prevention of vomiting induced by moderately emetogenic chemotherapy].
Di Maio M; Gallo C; Perrone F
Tumori; 2008; 94(2):suppl 14-22. PubMed ID: 18564621
[No Abstract] [Full Text] [Related]
9. Itasetron. DAU 6215, U 98079.
Drugs R D; 1999 Oct; 2(4):243-4. PubMed ID: 10659399
[No Abstract] [Full Text] [Related]
10. Palonosetron hydrochloride is an effective and safe option to prevent chemotherapy-induced nausea and vomiting in children.
Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Lastiri GG; Rivera-Márquez H; Villasis-Keever MA; Del Angel VW; Díaz FC; López-Aguilar E
Arch Med Res; 2008 Aug; 39(6):601-6. PubMed ID: 18662592
[TBL] [Abstract][Full Text] [Related]
11. Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.
Saito M; Tsukuda M
Expert Opin Pharmacother; 2010 Apr; 11(6):1003-14. PubMed ID: 20307224
[TBL] [Abstract][Full Text] [Related]
12. Palonosetron (Helsinn).
Stacher G
Curr Opin Investig Drugs; 2002 Oct; 3(10):1502-7. PubMed ID: 12431027
[TBL] [Abstract][Full Text] [Related]
13. Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist.
Navari RM
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1577-86. PubMed ID: 19929251
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial.
Yu Z; Liu W; Wang L; Liang H; Huang Y; Si X; Zhang H; Liu D; Zhang H
Support Care Cancer; 2009 Jan; 17(1):99-102. PubMed ID: 18825421
[TBL] [Abstract][Full Text] [Related]
15. Palonosetron (Aloxi) for prevention of nausea and vomiting due to cancer chemotherapy.
Med Lett Drugs Ther; 2004 Mar; 46(1179):27-8. PubMed ID: 15057189
[No Abstract] [Full Text] [Related]
16. Palonosetron.
Siddiqui MA; Scott LJ
Drugs; 2004; 64(10):1125-32; discussion 1133-4. PubMed ID: 15139789
[TBL] [Abstract][Full Text] [Related]
17. Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.
Musso M; Scalone R; Bonanno V; Crescimanno A; Polizzi V; Porretto F; Bianchini C; Perrone T
Support Care Cancer; 2009 Feb; 17(2):205-9. PubMed ID: 18839220
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacology and clinical experiences with serotonin (5-HT3) receptor antagonists].
Scholz J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):626-8. PubMed ID: 9445561
[No Abstract] [Full Text] [Related]
19. [Clinical role of palonosetron for patients receiving cisplatin-based chemotherapy].
Labianca R; Mandalà M; Clerici M
Tumori; 2008; 94(2):suppl 23-5. PubMed ID: 18564622
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of two antiemetic combinations palonosetron dexamethasone versus ondansetron dexamethasone in chemotherapy of head and neck cancer.
Kaushal J; Gupta MC; Kaushal V; Bhutani G; Dhankar R; Atri R; Verma S
Singapore Med J; 2010 Nov; 51(11):871-5. PubMed ID: 21140114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
